Adverse incident reporting pilot programme extended
This article was originally published in Clinica
Executive Summary
A six-month pilot programme of an EU initiative for the electronic exchange of adverse incident reports between manufacturers/distributors and medtech regulatory authorities has been extended. The programme began in January this year, with four EU countries taking part: Ireland, Germany, France and the UK. The aim of the programme is to evaluate the electronic submission of incidents which fit within the reporting criteria of the European Commission’s vigilance guidance document, meddev 2.12/1 revision 5.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.